Study at a glance
Does having more vitamin D receptors always mean a stronger response?
No. Receptor amount matters, but the response also depends on active vitamin D reaching the cell and on the other machinery needed to act on the signal. A smaller amount of receptor can sometimes be enough.
What controls how much vitamin D receptor a cell has?
Cells can change how much receptor protein they make and how quickly they break it down. These controls vary with the kind of cell and its condition.
Can active vitamin D help the receptor last longer?
In laboratory experiments with activated human immune cells, active vitamin D slowed receptor breakdown. This is evidence for one way receptor levels can change in those cells, not proof that the same effect occurs throughout the body.
Read the full article below ↓Vitamin D receptor abundance is often discussed as though more receptor must mean a proportionally larger vitamin D response. The evidence does not support that simple linear model. VDR abundance is itself regulated, receptor protein can be stabilised or degraded, and biological competence depends on much more than receptor quantity.
VDR expression is actively regulated
Zella and colleagues mapped regulatory elements controlling the mouse and human VDR genes. Their work identified multiple enhancer regions rather than a single simple promoter switch. This is important because receptor abundance is not merely a fixed property of a tissue: the VDR locus can respond to regulatory inputs and its control architecture differs by cellular context.
The consequence is that two tissues can contain the same receptor gene yet maintain very different receptor abundance. Differences can emerge from enhancer use, transcription-factor environment and the regulatory state of the cell.
Receptor amount is not a direct response meter
Lee and colleagues tested VDR expression in vivo with mouse and human BAC transgenes placed into VDR-null mice. The transgenes reproduced tissue-selective receptor expression and restored major receptor-dependent physiological functions. Crucially, the experimental system shows why receptor abundance and response cannot be treated as a one-to-one relationship: relatively low or restricted expression can remain biologically competent in a defined rescue setting.
This does not mean receptor amount is irrelevant. Very low or absent VDR can clearly become limiting. It means that the dose-response relationship between receptor abundance and physiology depends on tissue, regulatory reserve, ligand exposure and the downstream machinery available in that cell.
Protein stability adds another control layer
Kongsbak and colleagues studied activated human CD4+ T cells and found that vitamin D increased VDR protein partly by protecting the receptor from proteasomal degradation. The work separates receptor transcription from receptor turnover: a cell can alter VDR abundance not only by changing how much receptor it makes, but also by changing how rapidly receptor protein is removed.
The model boundary matters. This proteasomal-stabilisation evidence comes from activated human CD4+ T cells. It should not be presented as a universal mechanism operating identically in every tissue.
Expression, stability and competence are distinct
Three related but different questions therefore need to be kept separate. Expression asks how much VDR transcript or newly produced receptor is generated. Stability asks how long receptor protein persists. Signalling competence asks whether the receptor can participate effectively in ligand recognition, genomic regulation and a biological response.
A tissue can have detectable receptor without strong signalling if ligand, chromatin access or necessary regulatory partners are limiting. Conversely, a relatively modest receptor abundance may be sufficient where downstream machinery is favourable. This is one reason why ‘receptor sensitivity’ cannot be reduced to receptor density alone.
Why this matters for interpreting vitamin D responsiveness
Differences in VDR abundance can contribute to differences in responsiveness, but they are only one component. The genomic response also depends on where VDR can bind, whether regulatory regions are accessible, which cofactors are present and how the cell is otherwise programmed. Tissue physiology then adds further constraints.
The genomic side of this problem is developed in VDR Cistrome, Chromatin and 3D Genome Organisation. The interpretive distinction between receptor presence and response is summarised in Why VDR Presence Is Not the Same as Vitamin D Response.
Common genetic variation is a separate question from receptor abundance and turnover. For the governed evidence on common variants, see Vitamin D Receptor Polymorphisms.
The central interpretation
VDR abundance is a regulated biological variable, not a fixed dial that maps linearly onto response. Enhancer architecture can alter receptor expression; protein turnover can alter receptor persistence; and downstream context determines how much functional signalling a given amount of receptor can support. A useful model of vitamin D responsiveness must therefore distinguish receptor quantity from receptor competence.
For the broader receptor system, return to Vitamin D Receptors.
Primary evidence used in this synthesis
- Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription · Lee A. Zella, Mark B. Meyer, Robert D. Nerenz, Seong-Min Lee, Melissa L. Martowicz, J. Wesley Pike. PMID 19897601; PMCID PMC2802900; DOI 10.1210/me.2009-0140.
- The impact of VDR expression and regulation in vivo · Seong-Min Lee, Mark B. Meyer, Nancy A. Benkusky, Charles A. O’Brien, J. Wesley Pike. PMID 28602960; PMCID PMC5723236; DOI 10.1016/j.jsbmb.2017.06.002.
- Vitamin D Up-Regulates the Vitamin D Receptor by Protecting It from Proteasomal Degradation in Human CD4+ T Cells · Kongsbak M, von Essen MR, Boding L, et al. PMID 24792400; PMCID PMC4008591; DOI 10.1371/journal.pone.0096695.
Related reading
Vitamin D Up-Regulates the Vitamin D Receptor by Protecting It from Proteasomal Degradation in Human CD4+ T Cells
The aim of this study was to determine if and how 1,25(OH)2D3 by itself regulates VDR expression in human CD4+ T cells.
Original paper ↗Read more →Vitamin D receptor (VDR) expression in different molecular subtypes of canine mammary carcinoma
The molecular-based classification of canine mammary carcinomas (CMCs) has been the focus of much current research.
Original paper ↗Read more →Vitamin D Receptor (VDR) Genetic Variants: Relationship of FokI Genotypes with VDR Expression and Clinical Disease Activity in Systemic Lupus Erythematosus Patients
This study was aimed to determine the association of the VDR variants FokI (rs2228570), BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236) with susceptibility to the disease, VD status, VDR mRNA expression, and clinical disease activity in SLE patients.
Original paper ↗Read more →1,25(OH)2D3 Promotes Macrophage Efferocytosis Partly by Upregulating ASAP2 Transcription via the VDR-Bound Enhancer Region and ASAP2 May Affect Antiviral Immunity
The active form of vitamin D3, i.e., 1,25(OH)2D3, exerts an anti-inflammatory effect on the immune system, especially macrophage-mediated innate immunity.
Original paper ↗Read more →Adipose tissue inflammation and VDR expression and methylation in colorectal cancer
Lack of vitamin D (VD) has been associated with colorectal cancer (CRC).
Original paper ↗Read more →Context-dependent vitamin D immunoregulation: how a shared VDR-centered pathway generates distinct human immune outcomes
Vitamin D exerts antimicrobial, inflammatory, adaptive, and regulatory effects in human immunity, yet these actions can be perceived as contradictory.
Original paper ↗Read more →Diminished Vitamin D Receptor Protein Levels in Crohn’s Disease Fibroblasts: Effects of Vitamin D
Vitamin D receptor (VDR) mediates most of the biological functions of this hormone, and we aim to analyze here the expression of VDR in intestinal tissue, epithelial cells, and fibroblasts from CD patients.
Original paper ↗Read more →PPAR-γ, RXR-α, and VDR Expression in Gingival Tissues of Patients with Grade B and Grade C Periodontitis: A Cross-Sectional Clinical Immunohistochemistry Study
Forty-five participants were allocated to three groups: Group 1, healthy controls; Group 2, stage 3 grade B periodontitis; and Group 3, stage 3 grade C periodontitis.
Original paper ↗Read more →The Influence of Single Nucleotide Polymorphisms on Vitamin D Receptor Protein Levels and Function in Chronic Liver Disease
We investigated the role of VDR SNPs on VDR protein levels and function in patients with chronic liver disease.
Original paper ↗Read more →Vitamin D and omega-3 fatty acids attenuate MSG-induced neurodegeneration by modulating tau pathology, neuroinflammation, and VDR expression in rats
Fifty male Sprague Dawley rats were randomly allocated to a control, an MSG, and three treatment groups that received MSG and either Vit D or N-3 PUFA supplements in combinations or alone for 4 weeks.
Original paper ↗Read more →VDR FokI, Receptor Expression and Linked Haplotypes: Evidence Synthesis
Explore how common VDR polymorphisms including FokI, BsmI, ApaI and TaqI may influence receptor function, expression and vitamin D signalling.
Read more →Association between Vitamin D receptor (VDR) gene polymorphisms and hypertensive disorders of pregnancy: a systematic review and meta-analysis
This systematic review and meta-analysis aimed to comprehensively evaluate the association of the VDR gene polymorphisms with HDP susceptibility.
Original paper ↗Read more →BsmI, ApaI and TaqI Polymorphisms in the Vitamin D Receptor Gene (VDR) and Association with Lumbar Spine Pathologies: An Italian Case-Control Study
We aimed to evaluate the distribution of VDR BsmI, ApaI, and TaqI allele, genotype, and haplotype frequencies in an Italian cohort of 266 patients with lumbar spine disorders assessed by Magnetic Resonance Imaging and 252 asymptomatic controls.
Original paper ↗Read more →Growth, Dietary Intake, and Vitamin D Receptor (VDR) Promoter Genotype in Indonesian School-Age Children
The aim of this study was to assess the association between VDR gene polymorphism and dietary intake towards height-for-age z-score (HAZ) of elementary school children in Malang District, East Java.
Original paper ↗Read more →Interactions between vitamin D receptor (VDR) gene and Interleukin-6 gene and environment factors on coronary heart disease risk in a Chinese Han population
Stratified analysis for gene: smoking interaction was investigated by logistic regression.
Original paper ↗Read more →Prognostic significance of vitamin D receptor (VDR) gene polymorphisms in liver cirrhosis
Here, we investigated the association between BsmI, ApaI, TaqI and FokI VDR polymorphisms and the severity of liver cirrhosis in relation to serum cytokine and lipopolysaccharide binding protein (LBP) levels and their role on survival in cirrhotic patients.
Original paper ↗Read more →Single Nucleotide Polymorphisms in the Vitamin D Receptor Gene (VDR) May Have an Impact on Acute Pancreatitis (AP) Development: A Prospective Study in Populations of AP Patients and Alcohol-Abuse Controls
The aim of this study was to explore possible associations of the four SNPs in the VDR receptor gene in a population of acute pancreatitis patients and alcohol-abuse controls, and to investigate the association with acute pancreatitis (AP) susceptibility.
Original paper ↗Read more →The hormone-bound vitamin D receptor enhances the FBW7-dependent turnover of NF-κB subunits
Signaling by hormonal vitamin D, 1,25-dihydroxyvitamin D (1,25D) has attracted increasing interest because of its non-classical actions, particularly its putative anticancer properties and its role in controlling immune system function.
Original paper ↗Read more →VDR, SOD-2, and CYP24A1 Gene Expression in Different Genotypes of BsmI SNP of the Vitamin D Receptor Gene in Individuals with Hypovitaminosis
Objective: To evaluate the effect of the genotypes of BsmI single nucleotide polymorphism (SNP) of the VDR gene on VDR, SOD2, and CYP24A1 gene expression in individuals with low serum vitamin D levels.
Original paper ↗Read more →VDR-Related Alopecia and Unliganded Hair-Follicle Biology: Evidence Synthesis
Evidence synthesis of VDR mutation classes, alopecia and the evidence for unliganded VDR functions in hair-follicle biology.
Read more →Vitamin D Receptor Polymorphisms
Explains how vitamin D receptor polymorphisms contribute to variability in signalling and responsiveness across tissues without predicting outcomes or implying dysfunction.
Read more →Original sources
Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription
Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription · Lee A.
Publication details
Multifunctional enhancers regulate mouse and human vitamin D receptor gene transcription · Lee A. Zella, Mark B. Meyer, Robert D. Nerenz, Seong-Min Lee, Melissa L. Martowicz, J. Wesley Pike. PMID 19897601; PMCID PMC2802900; DOI 10.1210/me.2009-0140.
The impact of VDR expression and regulation in vivo
The impact of VDR expression and regulation in vivo · Seong-Min Lee, Mark B.
Publication details
The impact of VDR expression and regulation in vivo · Seong-Min Lee, Mark B. Meyer, Nancy A. Benkusky, Charles A. O’Brien, J. Wesley Pike. PMID 28602960; PMCID PMC5723236; DOI 10.1016/j.jsbmb.2017.06.002.
Vitamin D Up-Regulates the Vitamin D Receptor by Protecting It from Proteasomal Degradation in Human CD4+ T Cells
The aim of this study was to determine if and how 1,25(OH)2D3 by itself regulates VDR expression in human CD4+ T cells.
Publication details
Vitamin D Up-Regulates the Vitamin D Receptor by Protecting It from Proteasomal Degradation in Human CD4+ T Cells · Kongsbak M, von Essen MR, Boding L, et al. PMID 24792400; PMCID PMC4008591; DOI 10.1371/journal.pone.0096695.